Technical Analysis for PTN - Palatin Technologies, Inc.
Trend Table & Recent Alerts
|Weak or Absent||Down||Down||Up|
|See historical PTN trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 22||50 DMA Resistance||Bearish||0.00%|
|Jun 22||Bollinger Band Squeeze||Range Contraction||0.00%|
|Jun 22||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jun 21||Bollinger Band Squeeze||Range Contraction||6.94%|
|Jun 21||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||6.94%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Is PTN a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PTN news...
|52 Week High||0.9|
|52 Week Low||0.2851|
|200-Day Moving Average||0.4587|
|50-Day Moving Average||0.3894|
|20-Day Moving Average||0.3611|
|10-Day Moving Average||0.3598|
|Average True Range||0.0229|
|Chandelier Exit (Long, 3 ATRs)||0.3313|
|Chandelier Exit (Short, 3 ATRs)||0.4087|
|Upper Bollinger Band||0.3824|
|Lower Bollinger Band||0.3398|
|Percent B (%b)||1.06|
|MACD Signal Line||-0.0098|